On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...